You can buy Mounjaro online from UK Meds which will be delivered directly to your door. Your order includes a free private prescription which you get after a successful review of your online consultation questions by a doctor. It should be noted that Mounjaro needs to be stored in a fridge between 2°C to 8°C. It can be stored out of a fridge for up to 21 days, provided it is being stored below room temperature (30ºC).

Buy Tirzepatide UK

If you are looking to buy Mounjaro (tirzepatide) in the United Kingdom, look no further than UK Meds. Mounjaro can be purchased online from UK Meds after you have successfully completed our free online consultation and it has been reviewed by a doctor who will provide you with a free private prescription.

Mounjaro Private Prescription

Yes, you can get a private prescription online in the United Kingdom at UK Meds for Mounjaro. Our prescription service process is simple, complete our quick online consultation which will then be reviewed by a doctor. If approved, you will be given a free private Mounjaro prescription online. Once you have your Mounjaro prescription you can continue to purchase the Mounjaro pen at UK Meds. Please note that you should always consult with your doctor or healthcare professional before you start any new treatment to ensure that it is suitable for your needs and for any weight loss advice or a sustainable weight loss treatment plan.

Yes, you can buy Mounjaro (tirzepatide) online in the United Kingdom from UK Meds by completing our quick online consultation with our doctor. Your free private prescription will be issued if approved and your weight loss treatment will be dispensed.

Yes, in November 2023 Mounjaro was authorised by the Medicines and Healthcare Products Regulatory Agency (MHRA) for weight loss and management of type 2 diabetes to lower blood glucose levels (Drugs.com, 2024) in people over the age of 18 years old in the UK.

At UK Meds, you can purchase Mounjaro for as little as £169.99*. You can rest assured that UK Meds will always provide you with the best possible price for all of our products.

*Please note: The price stated was correct at the time of writing.

Mounjaro (pronounced 'mown-JAHR-OH') is a weekly self-injectable pen designed for type-2 diabetes and weight loss (Lilly, 2024). It contains tirzepatide, a key ingredient that regulates an individual's blood sugar level and energy balance levels, helping to curb appetite and prevent cravings (ScienceDirect, 2024). When used correctly, Mounjaro can help suitable patients in their weight loss journey to lose weight safely alongside a healthy balanced diet and regular exercise.

For more information on this prescription medication patients should refer to the Mounjaro patient information leaflet.

Each patient has a unique individual experience when taking Mounjaro weight loss injections as a treatment prescribed by their doctor for weight loss.

Mounjaro Reviews

There is a large selection of Mounjaro reviews describing what people think about their experiences with the medication available at Drugs.com and Web MD.

It is important to note that people will have different experiences when they use Mounjaro weight loss injections. If someone states that their medication did not work as they had hoped, it does not mean that it will not work for you. If you believe that Mounjaro is the right weight loss medication for you then the best thing to do is to consult your doctor, GP or healthcare provider. They can assess your suitability for the weight loss treatment and if it is approved you can judge the medication based on your own experiences. However, Mounjaro user experiences should not be understated as they can provide you with important advice and information that you may not have known, and can inform you on whether or not to start using Mounjaro. If you are unsure about starting a medication you should always consult with your healthcare provider first.

Mounjaro Before and After

Check out some independent Mounjaro user experiences below.

The table below explains how different weight loss treatments compare to each other:

The active ingredient in Mounjaro is called tirzepatide. This weight loss injection medication acts on two hormonal receptors: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) (Nauck & D’Alessio, 2022). These hormones help regulate blood sugar levels, reduce hunger, and keep you feeling fuller for longer by slowing down stomach emptying.

A clinical trial reported by Ellie Lilly & Company (2023) found that tirzepatide, that active ingredient in Mounjaro weight loss injections, achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes.

Further clinical trials have demonstrated that Mounjaro, when combined with healthy lifestyle changes, can lead to significant weight loss of at least 20% over 18 months (Singh, K.; 2024). This effectiveness is attributed to its active ingredient, tirzepatide, which regulates blood sugar levels and manages appetite, offering a promising solution for weight management when combined with a health lifestyle change.

Mounjaro is recommended for individuals with a BMI (Body Mass Index) over 30 (classified as obese) or over 27 (classified as overweight) who also have weight-related health problems such as prediabetes, high blood pressure, high cholesterol, or heart problems (GOV.UK, 2024). It's important to consult with a healthcare provider to determine if Mounjaro is suitable for you and to ensure proper usage and monitoring.

Mounjaro is administered as a weekly self-injectable pen, adjusting the dose knob as instructed by your doctor. You inject it under the skin (subcutaneously) in areas such as your stomach, thigh, or upper arm (Mounjaro, 2024). The dosage starts low and gradually increases until you reach the maintenance dose prescribed by your healthcare provider. It's essential to follow the dosage instructions provided by your healthcare provider and to rotate the Mounjaro weight loss injection sites regularly.

Read UK Meds simple step-by-step guide for how to take Mounjaro.

Mounjaro manufacturer, Eli Lilly and Company, has created a helpful video to explain instructions for taking the weight loss injection. You can watch it below:

The best places to inject Mounjaro are areas with more fat, such as your tummy (ensuring to inject more than 5cm away from your belly button), the front of your thighs, or your upper arms. It's crucial to change injection sites regularly, even if you inject in the same area, to avoid discomfort or skin issues (Drugs.com, 2023).

It is important that you only ever use the dosage of Mounjaro that you have been told to use by your healthcare provider. This will ensure that you are remaining safe whilst using the medication. Typically, your healthcare professionals will prescribe the lowest dosage of Mounjaro that provides the desired effect (Eisenstein, C.; 2023).

Below is a table that outlines how much Mounjaro is typically used:

Always consult your doctor if you have missed a dose of Mounjaro for appropriate advice. Typically, if you miss a dose of Mounjaro, you should take the missed dose as soon as possible within the following 4 days (96 hours) after the missed dose. If it has been more than 4 days since the missed dose window, skip the missed dose and take the next dose on the next regularly scheduled day. You should not take 2 doses of Mounjaro (tirzepatide injection) within 3 days of each other (Mounjaro, 2024).

Mounjaro can last for up to 21 days if it is unrefrigerated, as long as the external temperature does not go above 30°C; it is advised to keep your pen in the original packaging to protect it from light (Mounjaro, 2024).

Each Mounjaro pen contains 4 doses and because it is a weekly dosage one pen should last for 4 weeks.

Mounjaro is suitable for adults aged 18 and over with a BMI over 30 (classified as obese) or over 27 (classified as overweight) who also have weight-related health problems such as prediabetes, high blood pressure, high cholesterol, or heart problems (GOV.UK, 2023). 

Mounjaro is not suitable for individuals who are pregnant or breastfeeding, as well as those with certain medical conditions such as severe problems with digesting food, a history of pancreatitis, thyroid cancer, or allergies to tirzepatide or any of its ingredients (Weiser, P; 2023). It may not be suitable for individuals using certain other diabetes medications (Watson, A; 2023). It's crucial to consult with a healthcare provider to determine if Mounjaro is safe and appropriate for you based on your medical history and current health status.

No, your doctor will likely recommend not using Mounjaro (tirzepatide) if you are pregnant because it’s not currently known if it is safe to use during pregnancy (Weiser, P; 2023). It's important to discontinue the use of Mounjaro at least one month before attempting to become pregnant. If you are pregnant or planning to become pregnant, it's essential to discuss your options with a healthcare provider to ensure the safety of both you and your baby.

The safety of using Mounjaro while breastfeeding has not been established, it’s currently unknown if tirzepatide can be passed through to the newborn/infant in breastmilk so there could be a potential safety risk. Therefore, it is essential to consult with a healthcare provider before using Mounjaro if you are breastfeeding (EMC, 2024). They can provide guidance based on your individual circumstances and help you make an informed decision regarding the use of Mounjaro while breastfeeding.

Yes, there can be interactions between Mounjaro and other medications, you can check what these medications are at Drugs.com. It's crucial to inform your healthcare provider about all the medications, supplements, and herbal products you are currently taking before starting Mounjaro. This includes both prescription and over-the-counter medications. Your healthcare provider can then assess potential interactions and adjust your treatment plan accordingly to ensure your safety and optimise the effectiveness of your medications.

As with all other medications, some users may experience Mounjaro side effects when they are using the weight loss treatment (WebMD, 2024). There are some side effects that are more common than others. The most common side effects of Mounjaro include:

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Fatigue
• Lightheadedness
• Flatulence
• Gallstones

If you are concerned about any side effects you are experiencing with Mounjaro then it is recommended that you consult with your healthcare provider for advice.

Mounjaro comes with a few warnings you need to know about. It has a boxed warning about the increased risk of developing thyroid cancer as demonstrated in clinical studies (Lilly, 2023). It is important to fully read the additional information in the patient information leaflet provided with the medication before you use it. You may need to speak to your doctor if you have severe problems with food digestion, a history of pancreatitis, diabetic eye problems, or if you are using other diabetes medications like sulphonylureas or insulin, as it may increase the risk of low blood sugar. When you first start using Mounjaro, you will need to keep an eye out for signs of dehydration. 

Alternative weight loss medications for Mounjaro include Wegovy (semaglutide) and Saxenda (liraglutide). These medications offer different mechanisms of action and may be prescribed based on individual patient factors and preferences. It's important to discuss with your healthcare provider to determine the most suitable option for your specific needs and health condition.

Alternative diabetes treatment pens include Ozempic (semaglutide) injection pen. The diabetes treatment your doctor recommends will be prescribed on your individual circumstances to ensure that it is the safest and most appropriate treatment for you. 

Mounjaro and Saxenda are both weight-loss medications, but they have differences in their active ingredients and mechanisms of action (Drugs.com). Mounjaro contains tirzepatide, which works by regulating high and low blood sugar levels and curbing appetite through hormonal receptors. On the other hand, Saxenda contains liraglutide, which also acts on hormonal receptors to reduce appetite and promote weight loss. Additionally, the dosing frequency and administration method may vary between the two medications.

Mounjaro and Wegovy are both medications used for weight loss, but they have differences in their active ingredients (Drugs.com). Mounjaro contains tirzepatide, which regulates blood sugar levels and manages appetite. Wegovy, on the other hand, contains semaglutide, which also acts on hormonal receptors to reduce appetite and promote weight loss. 

Mounjaro and Ozempic are both medications that can be used to help manage type 2 diabetes (Drugs.com). While both medications have been shown to be effective in clinical trials, individual responses may vary, so it's important to consult with a healthcare provider to determine the most suitable option based on individual needs and medical history. In some countries, Ozempic can be used as a weight loss medication, however, this is not the case in the UK.

Yes, Mounjaro requires a valid prescription from a healthcare provider (Medical News Today, 2024). It is a prescription medication used for weight loss and management.

Below are answers to some of the most common questions that UK Meds customers ask about the weight loss medication Mounjaro (tirzepatide).

The Medicines and Healthcare Products Regulatory Agency (MHRA) authorised Mounjaro (tirzepatide) for weight loss and weight management in adults over the age of 18 years old on the 8th of November 2023 (GOV.UK, 2023). Mounjaro was launched to market in February 2024 (Reuters, 2024).

Yes, as of February 2024, Mounjaro is an approved medication in the United Kingdom for weight loss and weight management, available to buy for adults over the age of 18 years old with a valid prescription.

Availability on the NHS of Mounjaro may depend on various factors, including clinical guidelines, cost-effectiveness assessments, and individual patient eligibility criteria (Diabetes UK, 2024). To find out if Mounjaro is available on the NHS and if you are eligible to receive it through NHS prescriptions, you may wish to consult with your healthcare provider, however, an online method such as UK Meds offers easier access.

The National Institute for Health and Care Excellence (NICE) are currently conducting an appraisal for Mounjaro to be used for treating obese and overweight patients within the NHS, this is expected to conclude in March 2024 (Diabetes UK, 2024). You can also purchase Mounjaro on a private prescription from an online provider like UK Meds.

No, Mounjaro and Ozempic are not the same medications, although they share similarities in their mechanism of action. Mounjaro contains tirzepatide, while Ozempic contains semaglutide. Both medications belong to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Mounjaro is a weight loss medication, where as Ozempic is used for the treatment of type 2 diabetes.

No, Mounjaro and Saxenda are not the same medications, although they both serve the purpose of aiding weight loss. Mounjaro contains tirzepatide, while the alternative weight loss drug Saxenda contains liraglutide. Both medications belong to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and work by reducing appetite and promoting weight loss. However, they have different active ingredients and formulations.

No, Mounjaro and Wegovy are not the same medications, although they are both used for weight loss. Mounjaro contains tirzepatide, while Wegovy contains semaglutide. Both medications belong to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and help to manage appetite and promote weight loss. However, they have different active ingredients and formulations.

Switching from Ozempic to Mounjaro is possible and safe but should only be done under the guidance and supervision of your doctor (Verywell Health, 2023). As Ozempic is not licensed to help people lose weight in the UK, you should consult with your healthcare provider for further advice. Your healthcare provider can assess your individual health status, medication history, and treatment goals to determine if switching from Ozempic to Mounjaro is appropriate for you. 

The Mounjaro pen is manufactured by Eli Lilly and Company (Lilly, 2024). They are a pharmaceutical company known for developing various medications for a range of health conditions, including diabetes and weight management. They are a similar company to Novo Nordisk, the manufacturer of popular injection treatments for diabetes (Ozempic) and weight loss (Wegovy & Saxenda).

Yes, Mounjaro is a GLP-1 (glucagon-like peptide-1) receptor agonist (Diabetes UK, 2024). It contains tirzepatide, which acts as a GLP-1 receptor agonist to regulate high and low blood sugar levels, reduce appetite, and promote weight loss. This mechanism of action is similar to other medications in the GLP 1 receptor agonist class such as Wegovy, which are commonly used for the management of type 2 diabetes and weight loss.

Yes, Mounjaro and tirzepatide are the same thing. Mounjaro is the brand name of the GLP 1 medication, while tirzepatide is the active ingredient in Mounjaro (EMA, 2024). It's common for medications to have both a brand name and a generic or active ingredient name.

Clinical studies, funded by Eli Lilly and Company, are currently ongoing to assess if Mounjaro affects cardiovascular conditions; early indications suggest that it can significantly lower blood pressure (Medical News Today, 2024). Whether you can take Mounjaro if you have high blood pressure depends on your individual health status and the recommendation of your healthcare provider. Mounjaro is indicated for adults with a BMI over 30 (classified as obese) or over 27 (classified as overweight) who also have body weight-related health problems such as prediabetes, high blood pressure, high cholesterol, or heart problems.

The rate at which individuals lose weight with Mounjaro can vary significantly depending on factors such as diet, exercise, dosage, and individual response to the medication. Clinical trials have shown that patients could achieve at least 20% weight loss after using the Mounjaro active ingredient tirzepatide for 72 weeks when combined with healthy lifestyle changes (Velazquez, A.; 2023). Results with Mounjaro will vary from person to person, however, it is viewed as an effective weight loss medication.

Whilst fatigue is not listed as a potential side effect of Mounjaro by the manufacturer, Eli Lilly and Company, some Mounjaro user reviews do complain of fatigue after using the medication (Drugs.com, 2023). Additionally, fatigue can be a common side effect associated with type-2 diabetes (Kalra & Sahay, 2018). While not everyone will experience fatigue while taking the medication, it is one of the possible adverse effects. If you notice excessive tiredness or any other concerning symptoms while taking Mounjaro, it's important to discuss them with your healthcare provider. They can evaluate your symptoms and provide guidance on how to manage them effectively.

It is not currently known if the active ingredient in Mounjaro, tirzepatide, can cause the sexual health condition, erectile dysfunction (ED), further research is needed in this area to determine if erectile dysfunction could be a potential side effect tirzepatide (Cherney, 2024).

No. Evidence suggests that Mounjaro does not directly cause hair loss (alopecia). In most instances, hair loss when taking the tirzepatide weight loss injections is more likely to be due to the stress of rapid weight loss on your body (Anderson, L.; 2024).

• Mounjaro - What is Mounjaro
• Lilly - Mounjaro Media Kit
• Drugs.com - Mounjaro
• WebMD - Mounjaro Subcutaneous
• Pan Mersey APC - Tirzepatide T2DM
• Medicines.org.uk - Mounjaro (Summary of Product Characteristics)
• UK Government - Mounjaro KwikPen Approval
• NICE - TA924
• BNF - Tirzepatide
• Mayo Clinic - Tirzepatide Subcutaneous
• EMA - Mounjaro
• ScienceDirect - Tirzepatide

• How To Take Mounjaro: 8 Step Guide - UK Meds
• Mounjaro Shortage UK: Explaining the Short Supply of the Weight Loss Injection Pen